Addition of darbepoetin alfa to dose-dense chemotherapy: Results from a randomized phase II trial in small-cell lung cancer patients receiving carboplatin plus etoposide

Sylke Nagel, Olaf Kellner, Walburga Engel-Riedel, Sylvia Guetz, Christian Schumann, Frank Gieseler, Wolfgang Schuette*

*Corresponding author for this work
11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Addition of darbepoetin alfa to dose-dense chemotherapy: Results from a randomized phase II trial in small-cell lung cancer patients receiving carboplatin plus etoposide'. Together they form a unique fingerprint.

Medicine & Life Sciences